Nuplazid is the first and only FDA-approved therapy, proven to control hallucinations and delusions without impacting motor function for patients with Parkinson’s Disease Psychosis. In the core campaign art, the disease state is represented as “chaos” with a lot of elements on the brain. Through the treatment, the brain will go from “chaos” to “calm”, which was communicated digitally in a short video format.

  • Client ACADIA Pharmaceuticals